AstraZeneca's ENHERTU Enters Pivotal Phase 3 Trial for Endometrial Cancer
AstraZeneca (NASDAQ:AZN) is one of the 8 Best Inexpensive Stocks to Buy Right Now. On June 9, the first patient was dosed by AstraZeneca in the DESTINY-Endometrial01 phase 3 trial.